Pitrakinra for asthma

Bibliography

• Taylor DA, McGrath JL, O'Connor BJ, Barnes PJ. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. Am J Respir Crit Care Med 1998;158:99-106
   PubMed Web of Science ®Google Scholar
• Henderson AC, Ingenito EP, Atileh H, Selected contribution: how does airway inflammation modulate asthmatic airway constriction? An antigen challenge study. J Appl Physiol 2003;95:873-82
   PubMed Web of Science ®Google Scholar
• Sampson AP, Pizzichini E, Bisgaard H. Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation. J Allergy Clin Immunol 2003;111(1 Suppl):S49-59, discussion S59-61
   PubMedGoogle Scholar
• Gina Report, Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), (2009). Available from: http://ginasthma.org/Guidelineitem.asp??l1=2&l2=1&intId=1561 [Last accessed 16 September 2010]
   Google Scholar
• Negri J, Early SB, Steinke JW, Borish L. Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways. J Allergy Clin Immunol 2008;121:1232-7
   PubMed Web of Science ®Google Scholar
• Fukuda T, Fukushima Y, Numao T, Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 1996;14:84-94
   PubMed Web of Science ®Google Scholar
• Steinke JW, Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2001;2:66-70
   PubMed Web of Science ®Google Scholar
• Brusselle G, Kips J, Joos G, Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 1995;12:254-9
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Kips JC, Tavernier JH, Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73-80
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Brusselle GJ, Kips JC. Cytokine manipulation in animal models of asthma. Am J Respir Crit Care Med 1997;156:S78-81
   PubMed Web of Science ®Google Scholar
• Leonard C, Tormey V, Burke C, Poulter LW. Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am J Respir Cell Mol Biol 1997;17:368-75
   PubMedGoogle Scholar
• Shi HZ, Deng JM, Xu H, Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. Am J Respir Crit Care Med 1998;157:1818-21
   PubMed Web of Science ®Google Scholar
• Kasaian MT, Miller DK. IL-13 as a therapeutic target for respiratory disease. Biochem Pharmacol 2008;76:147-55
   PubMed Web of Science ®Google Scholar
• Wills-Karp M, Luyimbazi J, Xu X, Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61
   PubMed Web of Science ®Google Scholar
• Wills-Karp M. The gene encoding interleukin-13: a susceptibility locus for asthma and related traits. Respir Res 2000;1:19-23
   PubMedGoogle Scholar
• Wynn TA. IL-13 effector functions. Annu Rev Immunol 2003;21:425-56
   PubMed Web of Science ®Google Scholar
• Wills-Karp M. Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Rep 2004;4:123-31
   PubMed Web of Science ®Google Scholar
• Batra V, Musani AI, Hastie AT, Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004;34:437-44
   PubMed Web of Science ®Google Scholar
• Eum SY, Maghni K, Hamid Q, Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol 2003;111:1049-61
   PubMed Web of Science ®Google Scholar
• Prieto J, Lensmar C, Roquet A, Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 2000;94:806-14
   PubMed Web of Science ®Google Scholar
• Andrews AL, Nasir T, Bucchieri F, IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J Allergy Clin Immunol 2006;118:858-65
   PubMed Web of Science ®Google Scholar
• Feng N, Lugli SM, Schnyder B, The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Lab Invest 1998;78:591-602
   PubMed Web of Science ®Google Scholar
• Fish SC, Donaldson DD, Goldman SJ, IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13. J Immunol 2005;174:7716-24
   PubMed Web of Science ®Google Scholar
• Kolodsick JE, Toews GB, Jakubzick C, Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J Immunol 2004;172:4068-76
   PubMed Web of Science ®Google Scholar
• Ramalingam TR, Pesce JT, Sheikh F, Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol 2008;9:25-33
   PubMed Web of Science ®Google Scholar
• Webb DC, Mckenzie AN, Koskinen AM, Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 2000;165:108-13
   PubMed Web of Science ®Google Scholar
• Townley RG, Gendapodi PR, Qutna N, Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids. Ann Allergy Asthma Immunol 2009;102:190-7
   PubMed Web of Science ®Google Scholar
• Fukuyama S, Nakano T, Matsumoto T, Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype. Am J Respir Crit Care Med 2009;179:992-8
   PubMed Web of Science ®Google Scholar
• Gao YD, Zou JJ, Zheng JW, Promoting effects of IL-13 on Ca2+ release and store-operated Ca2+ entry in airway smooth muscle cells. Pulm Pharmacol Ther 2010;23(3):182-189
   PubMed Web of Science ®Google Scholar
• Chiba Y, Tanabe M, Goto K, Down-regulation of miR-133a contributes to up-regulation of RhoA in bronchial smooth muscle cells. Am J Respir Crit Care Med 2009;180:713-19
   PubMed Web of Science ®Google Scholar
• Chiba Y, Sato S, Hanazaki M, Inhibition of geranylgeranyltransferase inhibits bronchial smooth muscle hyperresponsiveness in mice. Am J Physiol Lung Cell Mol Physiol 2009;297:L984-91
   PubMed Web of Science ®Google Scholar
• Tomkinson A, Tepper J, Morton M, Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma. Allergy 2010;65:69-77
   PubMed Web of Science ®Google Scholar
• Burmeister Getz E, Fisher DM, Fuller R. Human pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma. J Clin Pharmacol 2009;49:1025-36
   PubMed Web of Science ®Google Scholar
• Wenzel S, Wilbraham D, Fuller R, Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 2007;370:1422-31
   PubMed Web of Science ®Google Scholar
• Antoniu SA. Cytokine antagonists for the treatment of asthma: progress to date. BioDrugs 2009;23:241-51
   PubMed Web of Science ®Google Scholar